Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

82
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
82
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

46
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
46
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

48
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
48
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.6K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

58
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Obesity a Factor in Lethal Opioid Toxicity?

The American journal of forensic medicine and pathology·2025
Same author

The importance of outliers in forensic practice.

Journal of forensic and legal medicine·2025
Same author

Physical exercise therapy for chronic non-specific neck pain: protocol for a meta-analysis of individual participant data.

Systematic reviews·2025
Same author

Increasing age and lethal opiate use.

Medicine, science, and the law·2024
Same author

Difficulties associated with the interpretation of postmortem toxicology.

Journal of analytical toxicology·2024
Same author

Recent trends in an uncommon method of carbon monoxide suicide.

Forensic science, medicine, and pathology·2024

Related Experiment Video

Updated: Sep 25, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.1K

Cardiac disease and driver fatality.

Siobhan O'Donovan1,2, Melissa Humphries3, Corinna van den Heuvel1

  • 1School of Biomedicine, The University of Adelaide, Level 2, Room N237, Helen Mayo North, Frome Road, Adelaide, SA, 5005, Australia.

Forensic Science, Medicine, and Pathology
|April 25, 2022
PubMed
Summary

Cardiac disease is not a significant factor in driver fatalities from crashes. However, a growing number of drivers are dying from cardiac events while driving, particularly in an aging population.

Keywords:
ElderFatalityForensicIschemic heart diseaseVehicle crash

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.4K

Related Experiment Videos

Last Updated: Sep 25, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.1K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.4K

Area of Science:

  • Forensic Pathology
  • Cardiovascular Research
  • Traffic Safety

Background:

  • Cardiac disease is a leading cause of death globally.
  • The role of cardiac events in motor vehicle accidents requires further investigation.
  • Driver demographics are shifting towards an older population.

Purpose of the Study:

  • To investigate the prevalence of cardiac disease in drivers who died in motor vehicle accidents.
  • To compare the incidence of coronary artery atherosclerosis (CAA) and cardiomegaly in drivers versus passengers.
  • To determine if cardiac disease contributes to driver fatalities in crashes.

Main Methods:

  • Retrospective review of autopsy files from Forensic Science SA (Adelaide, Australia) from January 2005 to December 2017.
  • Analysis included drivers aged ≥40 years who died while driving.
  • Comparison group: passengers aged ≥40 years who died of trauma; drivers aged ≥40 years who died of a cardiac event while driving.

Main Results:

  • Among drivers who died of trauma (n=303), 15.8% had CAA and 10.2% had cardiomegaly.
  • These rates were not statistically different from passengers (n=72) who died of trauma (20.8% CAA, 15.2% cardiomegaly; p>0.2).
  • A distinct subgroup of 63 drivers died from cardiac events, not trauma, while driving.

Conclusions:

  • Significant coronary artery atherosclerosis and cardiomegaly were not associated with increased driver fatalities in motor vehicle crashes.
  • A notable subgroup of drivers died from primary cardiac events while operating a vehicle.
  • The incidence of drivers dying from cardiac events while driving may increase with an aging population.